Search Within

Michael Andrew Postow

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (7)
  3. Research Letter (2)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (36)
  2. Department of Pathology and Laboratory Medicine (36)
  3. Melanoma Disease Management Team (36)
  4. Melanoma and Immunotherapeutics Service (36)
  5. Solid Tumor Oncology Division (36)
  6. GSK Faculty (23)

More Groups

People
  1. Alexander Shoushtari (17)
  2. Margaret Callahan (14)
  3. Jedd Wolchok (13)
  4. Klaus Busam (9)
  5. Paul Chapman (9)
  6. Michael Berger (8)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (5)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Clinical Cancer Research (3)
  3. Journal for ImmunoTherapy of Cancer (3)
  4. The Oncologist (3)
  5. Journal of the National Comprehensive Cancer Network (2)
  6. Nature (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Nature Publishing Group (6)
  3. American Association for Cancer Research (4)
  4. Oxford University Press (4)
  5. Biomed Central Ltd (3)
  6. Cell Press (2)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management and outcomes of clostridioides difficile infection in patients on immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Satish, D.; Kamboj, M.; Babady, N. E.; Baul, J.; Kalvin, H. L.; Panageas, K.; Postow, M. A.; Laszkowska, M.; Faleck, D. M.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma
    Journal Article

    Smithy, J. W.; Peng, X.; Ehrich, F. D.; Moy, A. P.; Yosofvand, M.; Maher, C.; Aleynick, N.; Vanguri, R.; Zhuang, M.; Lee, J.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab
    Journal Article

    Lochrin, S. E.; Buonocore, D. J.; Young, R. J.; Kaley, T. J.; Postow, M. A.; Wolchok, J. D.; Shoushtari, A. N.; Momtaz, P.; Betof Warner, A. S.; Callahan, M. K.
    Pigment Cell & Melanoma Research (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Corso, T.; Livingstone, P.; Tom, E.; Srivastava, A.; Postow, M.; Faleck, D.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
    Journal Article

    Widman, A. J.; Shah, M.; Frydendahl, A.; Halmos, D.; Khamnei, C. C.; Øgaard, N.; Rajagopalan, S.; Arora, A.; Deshpande, A.; Hooper, W. F.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Prevalence of enteric infections in patients on immune checkpoint inhibitors and impact on management and outcomes
    Journal Article

    Magahis, P. T.; Satish, D.; Babady, N. E.; Kamboj, M.; Postow, M. A.; Laszkowska, M.; Faleck, D. M.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save